| __timestamp | Halozyme Therapeutics, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 75334000 | 301600000 |
| Thursday, January 1, 2015 | 135057000 | 293461000 |
| Friday, January 1, 2016 | 146691000 | 301853000 |
| Sunday, January 1, 2017 | 316613000 | 331378000 |
| Monday, January 1, 2018 | 151862000 | 343374000 |
| Tuesday, January 1, 2019 | 195992000 | 347337000 |
| Wednesday, January 1, 2020 | 267594000 | 339410000 |
| Friday, January 1, 2021 | 443310000 | 425208000 |
| Saturday, January 1, 2022 | 660116000 | 935061000 |
| Sunday, January 1, 2023 | 829253000 | 1296429000 |
| Monday, January 1, 2024 | 1015324000 |
In pursuit of knowledge
In the competitive landscape of biotechnology and pharmaceuticals, Halozyme Therapeutics, Inc. and Lantheus Holdings, Inc. have been vying for revenue supremacy. Over the past decade, Lantheus has consistently outpaced Halozyme, with a notable 56% higher revenue in 2023. Starting in 2014, Lantheus held a 300% revenue advantage, which it maintained through strategic growth and market expansion. By 2021, both companies saw significant revenue increases, with Halozyme achieving a 67% growth from the previous year, while Lantheus surged by 120% in 2022. This trend highlights Lantheus's robust market position and strategic advancements. As the industry evolves, these companies continue to innovate, with Lantheus leading the charge in revenue generation. The data underscores the dynamic nature of the biotech sector, where strategic decisions and market conditions can dramatically shift financial outcomes.
Comparing Revenue Performance: Merck & Co., Inc. or Lantheus Holdings, Inc.?
Novartis AG vs Halozyme Therapeutics, Inc.: Annual Revenue Growth Compared
United Therapeutics Corporation and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis
Bio-Techne Corporation and Lantheus Holdings, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Catalent, Inc. or Halozyme Therapeutics, Inc.
Revenue Showdown: Jazz Pharmaceuticals plc vs Lantheus Holdings, Inc.
Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Comparing SG&A Expenses: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc. Trends and Insights
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Revenue Showdown: Halozyme Therapeutics, Inc. vs Geron Corporation
Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Lantheus Holdings, Inc. or Merus N.V.